Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
3.480
-0.140 (-3.87%)
At close: Mar 18, 2026, 4:00 PM EDT
3.400
-0.080 (-2.30%)
After-hours: Mar 18, 2026, 6:37 PM EDT
Turn Therapeutics Market Cap
Turn Therapeutics has a market cap or net worth of $102.47 million as of March 18, 2026.
Market Cap
102.47M
Enterprise Value
99.45M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.48
Market Cap Chart
Since October 8, 2025, Turn Therapeutics's market cap has decreased from $196.16M to $102.47M, a decrease of -47.76%. That is a compound annual growth rate of -77.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 106.59M | -8.12% |
| Dec 31, 2025 | 116.01M | -40.86% |
| Oct 8, 2025 | 196.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inovio Pharmaceuticals | 114.69M |
| Aardvark Therapeutics | 110.83M |
| Oncolytics Biotech | 105.88M |
| Agenus | 105.43M |
| Verrica Pharmaceuticals | 104.96M |
| Seer, Inc. | 102.69M |
| Gossamer Bio | 101.17M |
| Q32 Bio | 99.77M |